Surgical approaches for infratemporal fossa tumor resection: Fifteen years' experience of a single center
| Autor: | Helena Moshe‐Levyn, Dan M. Fliss, Irit Duek, Arik Zaretski, Anat Wengier, Daniel Yafit, Sara Abu-Ghanem, Nidal Muhanna, Omer J Ungar, Nevo Margalit, Avraham Abergel, Ravit Yanko-Arzi |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Adult
Male medicine.medical_specialty Adolescent Pterygopalatine Fossa medicine.medical_treatment Malignancy Single Center Skull Base Neoplasms Young Adult 03 medical and health sciences 0302 clinical medicine medicine Adjuvant therapy Humans Child 030223 otorhinolaryngology Aged Retrospective Studies Aged 80 and over Zygoma Chemotherapy Surgical approach business.industry Patient Selection Carcinoma Infratemporal fossa Infant Endoscopy Sarcoma Middle Aged Plastic Surgery Procedures medicine.disease Combined Modality Therapy Surgery Survival Rate Radiation therapy Treatment Outcome medicine.anatomical_structure Otorhinolaryngology Child Preschool Female business Infratemporal Fossa Orbit Craniotomy 030217 neurology & neurosurgery |
| Zdroj: | Head & Neck. 41:3755-3763 |
| ISSN: | 1097-0347 1043-3074 |
| DOI: | 10.1002/hed.25906 |
| Popis: | BACKGROUND The aims of this study were to report our center's experience with infratemporal fossa (ITF) tumors, to review the treatment modalities and outcomes. METHODS Data of patients that underwent resection of ITF tumors in a single tertiary referral medical center were collected and analyzed. RESULTS Sixty-three patients were included. Sarcoma was the most common pathology (18; 29%). The most common surgical approach was the preauricular-orbitozygomatic approach (24; 38%), followed by endoscopic, craniofacial resection, and combined approaches. Forty-seven patients (75%) required reconstruction, 23 (49%) involving free tissue transfer. Thirty-five patients (76%) with malignant lesions required adjuvant therapy consisting of radiotherapy, chemotherapy, or both. Thirty-three patients suffered from complications related to surgery or adjuvant therapy. The three- and five-years survival rates for malignancy were 82% and 66%, respectively. CONCLUSION Complete surgical resection of ITF involving tumors is feasible, providing good long-term survival. Multidisciplinary approach is the key for success. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text